<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2344
  </number>
  <updateDate>
   2023-01-11T13:48:54Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:54Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-01
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 59 (Thursday, April 1, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. RYAN:H.R. 2344.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 ``To make all Laws which shall benecessary and proper for carrying into Execution theforegoing Powers, and all other Powers vested by thisConstitution in the Government of the United States, or inany Department or Officer thereof.''[Page H1708]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-02T15:12:12Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-01T13:01:00Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     CARA 3.0 Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     4341
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2022-11-01
     </actionDate>
     <text>
      Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     CARA 3.0 Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     987
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-25
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Prescription Drug Monitoring Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     889
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-22
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-04-02
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-01
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-01
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-01
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     R000577
    </bioguideId>
    <fullName>
     Rep. Ryan, Tim [D-OH-13]
    </fullName>
    <firstName>
     TIM
    </firstName>
    <lastName>
     RYAN
    </lastName>
    <party>
     D
    </party>
    <state>
     OH
    </state>
    <district>
     13
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001306
    </bioguideId>
    <fullName>
     Rep. Balderson, Troy [R-OH-12]
    </fullName>
    <firstName>
     Troy
    </firstName>
    <lastName>
     Balderson
    </lastName>
    <party>
     R
    </party>
    <state>
     OH
    </state>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-04-01
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Criminal justice information and records
     </name>
    </item>
    <item>
     <name>
      Drug trafficking and controlled substances
     </name>
    </item>
    <item>
     <name>
      Health information and medical records
     </name>
    </item>
    <item>
     <name>
      Health personnel
     </name>
    </item>
    <item>
     <name>
      Intergovernmental relations
     </name>
    </item>
    <item>
     <name>
      Licensing and registrations
     </name>
    </item>
    <item>
     <name>
      Medical ethics
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      State and local government operations
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-01
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-08T18:55:45Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Prescription Drug Monitoring Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.&lt;/p&gt; &lt;p&gt;States or territories that receive this funding must require &lt;/p&gt; &lt;ul&gt; &lt;li&gt;prescribers to consult the PDMP before starting treatment with such drugs, and&lt;/li&gt; &lt;li&gt;dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Prescription Drug Monitoring Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Prescription Drug Monitoring Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To require the use of prescription drug monitoring programs.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Prescription Drug Monitoring Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-01T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2344ih/xml/BILLS-117hr2344ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-02
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-01
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-04-01
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-01
9
Library of Congress
Introduced in House
IntroReferral
2021-04-01T13:01:00Z
Referred to
House
Energy and Commerce Committee
2021-04-02T15:12:12Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
B001306
12
Troy
Rep. Balderson, Troy [R-OH-12]
Balderson
R
2021-04-01
OH
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-01
2021-04-02
Referred to the Subcommittee on Health.
House
Health
2022-11-01
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
CARA 3.0 Act of 2021
HR
2021-03-25
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
CARA 3.0 Act of 2021
S
2021-03-22
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Prescription Drug Monitoring Act of 2021
S
R000577
13
TIM
Rep. Ryan, Tim [D-OH-13]
N
RYAN
D
OH
Criminal justice information and records Drug trafficking and controlled substances Health information and medical records Health personnel Intergovernmental relations Licensing and registrations Medical ethics Prescription drugs State and local government operations
2021-04-01
Introduced in House
 <p><b>Prescription Drug Monitoring Act of 2021</b></p> <p>This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.</p> <p>States or territories that receive this funding must require </p> <ul> <li>prescribers to consult the PDMP before starting treatment with such drugs, and</li> <li>dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.</li> </ul> <p>In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.</p>
2021-06-08T18:55:45Z
00
2021-04-01T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2344ih/xml/BILLS-117hr2344ih.xml
Prescription Drug Monitoring Act of 2021
Prescription Drug Monitoring Act of 2021
Display Title
IH
Introduced in House
To require the use of prescription drug monitoring programs.
Official Title as Introduced
IH
Introduced in House
Prescription Drug Monitoring Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:54Z
2023-01-11T13:48:54Z
3.0.0
2022-11-01
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
CARA 3.0 Act of 2021
HR
2021-03-25
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
CARA 3.0 Act of 2021
S
2021-03-22
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Prescription Drug Monitoring Act of 2021
S
2021-04-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-01
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-04-01
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-01
9
Library of Congress
Introduced in House
IntroReferral
R000577
13
TIM
Rep. Ryan, Tim [D-OH-13]
N
RYAN
D
OH
B001306
12
Troy
Rep. Balderson, Troy [R-OH-12]
Balderson
R
2021-04-01
OH
Criminal justice information and records Drug trafficking and controlled substances Health information and medical records Health personnel Intergovernmental relations Licensing and registrations Medical ethics Prescription drugs State and local government operations
2021-04-01
Introduced in House
 <p><b>Prescription Drug Monitoring Act of 2021</b></p> <p>This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.</p> <p>States or territories that receive this funding must require </p> <ul> <li>prescribers to consult the PDMP before starting treatment with such drugs, and</li> <li>dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.</li> </ul> <p>In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.</p>
2021-06-08T18:55:45Z
00
Prescription Drug Monitoring Act of 2021
Prescription Drug Monitoring Act of 2021
Display Title
IH
Introduced in House
To require the use of prescription drug monitoring programs.
Official Title as Introduced
IH
Introduced in House
Prescription Drug Monitoring Act of 2021
Short Title(s) as Introduced
2021-04-02
Referred to the Subcommittee on Health.